Background The clinicopathological and prognostic significance of SRY-box transcription
factor 9 (SOX9) expression in gastric cancer (GC) patients is still controversial. Our aim is to …

Objective To investigate the association of SOX9 expression and clinicopathologic factors
and prognosis of gastric cancer. Methods A retrospective cohort study including 112 gastric …

Gastric cancer is one of the most frequent tumours and the third leading cause of cancer‐
related death worldwide. The investigation of new biomarkers that can predict patient …

Background: The sex-determining region Y-box 2 (SOX2) has been identified to be involved
in tumor progression and prognosis in patients with gastric cancer (GC). However, its action …

To investigate the SOX9 expression and its effects on promoting invasion and metastasis in
the primary gastric adenocarcinomas. One hundred and eighty six patients with primary …

Objective The aim of the this study was to analyze the status of sex-determining region Y-
related high-mobility group box 4 (SOX4) expression in varied human cancers and its …

Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little
is known about the molecular process by which this disease develops and progresses. This …

Background: The expression of sex-determining region Y (SRY)-like high-mobility group
(HMG) box 2 (SOX2) in gastric cancer and the prognosis of patients are controversial. This …

Purpose To investigate the potential role of SOX2 in gastric cancer (GC) metastasis.
Methods The SOX2 expression was detected using immunohistochemistry on a GC tissue …

Introduction: Recent comprehensive genetic and molecular profiling has identified molecular
subtypes of gastric cancer (GC) and has linked them to clinical information. Moreover, SOX9 …